ArticleFood chemistry: X2024
Efficient preparation of
Article in Food chemistry: X, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The study focuses on the efficient production of curdlan β-1,3-glucooligosaccharides (CDOS) through microwave-assisted hydrothermal hydrolysis of curdlan. The optimal condition was identified as 170 °C and 30 min, resulting in a curdlan liquefaction yield of over 96%, mainly contains CDOS along with minor amounts of glucose and 5-hydroxymethylfurfural (5-HMF). Oligosaccharides with a low degree of polymerization (DP), specifically DP2 to DP6, were isolated. The yields for DP2 to DP6 were 15.87%, 8.33%, 6.00%, 3.13%, and 1.83%, respectively, with purities over 70%. X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM) analysis demonstrated that the dense triple helix structure of the crystalline structure was disrupted during degradation. Additionally, CDOS at a concentration of 2.5 mg/mL partially inhibited the growth of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.